Q3 2024 |
69 |
$202M |
+$7.32M |
-$69.2M |
-$61.9M |
ETR, AMGN, VZ, TXN, CFR
|
13F-HR |
10/15/2024, 10:23 AM |
Q2 2024 |
71 |
$248M |
+$1.86M |
-$8.32M |
-$6.46M |
UL, GD, AMGN, TXN, JPM
|
13F-HR |
7/15/2024, 02:33 PM |
Q1 2024 |
69 |
$261M |
+$16.3M |
-$12.6M |
+$3.74M |
MRK, GD, CFR, UL, VZ
|
13F-HR |
4/5/2024, 02:03 PM |
Q4 2023 |
70 |
$245M |
+$11.2M |
-$18.1M |
-$6.86M |
JPM, AMGN, CFR, GD, MSM
|
13F-HR |
1/5/2024, 06:41 PM |
Q3 2023 |
72 |
$238M |
+$4.43M |
-$5.5M |
-$1.08M |
JPM, UL, AMGN, MSM, CMCSA
|
13F-HR |
10/13/2023, 01:14 PM |
Q2 2023 |
72 |
$246M |
+$13.2M |
-$9.28M |
+$3.89M |
UL, JPM, MRK, JNJ, MSM
|
13F-HR |
7/17/2023, 03:35 PM |
Q1 2023 |
70 |
$240M |
+$27.3M |
-$26M |
+$1.29M |
UL, JPM, TXN, MRK, VZ
|
13F-HR |
4/5/2023, 04:48 PM |
Q4 2022 |
71 |
$242M |
+$8.75M |
-$10.4M |
-$1.62M |
PFE, UL, XOM, MRK, JPM
|
13F-HR |
1/5/2023, 02:43 PM |
Q3 2022 |
77 |
$216M |
+$25.2M |
-$3.82M |
+$21.4M |
PFE, UL, JNJ, XOM, AMGN
|
13F-HR |
10/6/2022, 01:18 PM |
Q2 2022 |
71 |
$211M |
+$12.1M |
-$3.89M |
+$8.24M |
PFE, UL, JNJ, VZ, AMGN
|
13F-HR |
7/8/2022, 12:56 PM |
Q1 2022 |
70 |
$219M |
+$15.3M |
-$9.58M |
+$5.71M |
CVX, PFE, JNJ, GD, JPM
|
13F-HR |
4/6/2022, 11:01 AM |
Q4 2021 |
69 |
$212M |
+$5.68M |
-$4.3M |
+$1.38M |
PFE, JPM, CSCO, TXN, JNJ
|
13F-HR |
1/6/2022, 06:17 PM |
Q3 2021 |
68 |
$198M |
+$4.27M |
-$1.52M |
+$2.75M |
PFE, JPM, USB, INTC, TXN
|
13F-HR |
10/6/2021, 12:16 PM |
Q2 2021 |
68 |
$197M |
+$6.11M |
-$2.96M |
+$3.14M |
JPM, PFE, TXN, USB, JNJ
|
13F-HR |
7/6/2021, 03:53 PM |
Q1 2021 |
69 |
$188M |
+$13.8M |
-$8.48M |
+$5.36M |
JPM, PFE, TXN, USB, JNJ
|
13F-HR |
4/14/2021, 12:18 PM |
Q4 2020 |
67 |
$171M |
+$10.2M |
-$3.45M |
+$6.77M |
TXN, PFE, JPM, JNJ, MSM
|
13F-HR |
1/7/2021, 01:54 PM |
Q3 2020 |
63 |
$150M |
+$14.4M |
-$9.86M |
+$4.5M |
UPS, PFE, AMGN, TXN, JNJ
|
13F-HR |
10/7/2020, 06:00 PM |
Q2 2020 |
60 |
$142M |
+$10.9M |
-$14.4M |
-$3.57M |
PFE, UPS, AMGN, JNJ, MSFT
|
13F-HR |
7/7/2020, 03:43 PM |
Q1 2020 |
58 |
$131M |
+$20M |
-$26.2M |
-$6.18M |
PFE, JNJ, AMGN, UPS, GILD
|
13F-HR |
4/21/2020, 03:29 PM |
Q4 2019 |
62 |
$169M |
+$21.9M |
-$8.84M |
+$13.1M |
PFE, JPM, JNJ, AMGN, CVX
|
13F-HR |
1/31/2020, 04:23 PM |
Q3 2019 |
53 |
$149M |
+$18.1M |
-$13.5M |
+$4.66M |
PFE, JNJ, GSK, JPM, AAPL
|
13F-HR |
11/20/2019, 12:37 PM |
Q2 2019 |
50 |
$141M |
+$12.3M |
-$5.57M |
+$6.78M |
PFE, JNJ, CSCO, SBUX, GSK
|
13F-HR |
8/12/2019, 02:36 PM |
Q1 2019 |
61 |
$130M |
+$18.9M |
-$7.34M |
+$11.5M |
PFE, JNJ, CSCO, GSK, SBUX
|
13F-HR |
5/7/2019, 06:19 PM |
Q4 2018 |
49 |
$108M |
+$12.4M |
-$7.56M |
+$4.8M |
PFE, SBUX, JNJ, PG, AMGN
|
13F-HR |
2/13/2019, 05:55 PM |
Q3 2018 |
58 |
$112M |
+$10.1M |
-$2.43M |
+$7.64M |
PFE, JNJ, AAPL, CSCO, AMGN
|
13F-HR |
11/14/2018, 05:06 PM |
Q2 2018 |
45 |
$96.9M |
+$5.15M |
-$8.78M |
-$3.63M |
PFE, JNJ, GSK, RDSB, CVX
|
13F-HR |
8/13/2018, 05:23 PM |
Q1 2018 |
44 |
$100M |
+$8.37M |
-$1.71M |
+$6.66M |
CSCO, PFE, JNJ, GSK, AAPL
|
13F-HR |
5/14/2018, 02:02 PM |
Q4 2017 |
44 |
$96.3M |
$0 |
$0 |
|
JNJ, CSCO, PFE, BA, AAPL
|
13F-HR |
2/13/2018, 12:40 PM |